Organic Payment Gateways Targets Ketamine Clinic Payment Instability

The ketamine therapy sector is navigating a volatile landscape where high-growth potential meets rigid financial gatekeeping. While the market was valued at $3.41 billion in 2023, many legitimate, licensed clinics struggle to maintain stable credit card processing. Because these facilities often operate in a high-risk category due to the nature of controlled substances and off-label usage, mainstream processors frequently trigger automatic shutdowns, leaving practitioners unable to collect payments for services rendered.

Alex Roy, owner of Organic Payment Gateways, notes that the disruption often stems from broad, industry-wide compliance rules that fail to distinguish between ethical medical providers and high-risk merchants. To counter this, the firm conducts manual reviews of a clinic’s business model and licensing to secure underwritten merchant accounts. This approach allows psychiatry-led clinics, infusion centers, and esketamine facilities to maintain payment infrastructure—including in-office terminals and patient portal billing—without overhauling their existing software. By prioritizing direct, human-led support and transparent underwriting, the company aims to provide a reliable alternative for providers who are otherwise sidelined by the automated policies of larger financial platforms.